Researchers Announce They Are Stopping Trial of New Mesothelioma Drug,...

The makers of anetumab ravtansine say it failed to improve mesothelioma survival better than another drug.(PRWeb July 27, 2017)Read the full story at http://www.prweb.com/releases/2017/07/prweb14549214.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news